The active substance sedaxane, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Art. 1 Commission Implementing Regulation (EU) No 826/2013 of 29 August 2013 approving the acti…
Approval of active substance
In forcesince 29 Aug 2013